S&P 500   3,896.66 (-0.13%)
DOW   31,577.05 (+0.13%)
QQQ   321.37 (-0.69%)
AAPL   126.29 (-1.17%)
MSFT   235.01 (-0.81%)
FB   265.07 (+0.06%)
GOOGL   2,076.86 (+0.35%)
TSLA   703.97 (-2.01%)
AMZN   3,139.33 (-0.22%)
NVDA   545.72 (-1.44%)
BABA   238.35 (-1.38%)
CGC   35.52 (+2.27%)
GE   13.04 (-0.53%)
MU   92.15 (-2.75%)
NIO   44.39 (-10.79%)
AMD   85.68 (-0.82%)
T   28.31 (+0.78%)
F   12.58 (+5.01%)
ACB   11.35 (+2.81%)
DIS   194.48 (-0.26%)
BA   224.02 (-0.16%)
NFLX   551.93 (+0.23%)
BAC   35.59 (-0.56%)
S&P 500   3,896.66 (-0.13%)
DOW   31,577.05 (+0.13%)
QQQ   321.37 (-0.69%)
AAPL   126.29 (-1.17%)
MSFT   235.01 (-0.81%)
FB   265.07 (+0.06%)
GOOGL   2,076.86 (+0.35%)
TSLA   703.97 (-2.01%)
AMZN   3,139.33 (-0.22%)
NVDA   545.72 (-1.44%)
BABA   238.35 (-1.38%)
CGC   35.52 (+2.27%)
GE   13.04 (-0.53%)
MU   92.15 (-2.75%)
NIO   44.39 (-10.79%)
AMD   85.68 (-0.82%)
T   28.31 (+0.78%)
F   12.58 (+5.01%)
ACB   11.35 (+2.81%)
DIS   194.48 (-0.26%)
BA   224.02 (-0.16%)
NFLX   551.93 (+0.23%)
BAC   35.59 (-0.56%)
S&P 500   3,896.66 (-0.13%)
DOW   31,577.05 (+0.13%)
QQQ   321.37 (-0.69%)
AAPL   126.29 (-1.17%)
MSFT   235.01 (-0.81%)
FB   265.07 (+0.06%)
GOOGL   2,076.86 (+0.35%)
TSLA   703.97 (-2.01%)
AMZN   3,139.33 (-0.22%)
NVDA   545.72 (-1.44%)
BABA   238.35 (-1.38%)
CGC   35.52 (+2.27%)
GE   13.04 (-0.53%)
MU   92.15 (-2.75%)
NIO   44.39 (-10.79%)
AMD   85.68 (-0.82%)
T   28.31 (+0.78%)
F   12.58 (+5.01%)
ACB   11.35 (+2.81%)
DIS   194.48 (-0.26%)
BA   224.02 (-0.16%)
NFLX   551.93 (+0.23%)
BAC   35.59 (-0.56%)
S&P 500   3,896.66 (-0.13%)
DOW   31,577.05 (+0.13%)
QQQ   321.37 (-0.69%)
AAPL   126.29 (-1.17%)
MSFT   235.01 (-0.81%)
FB   265.07 (+0.06%)
GOOGL   2,076.86 (+0.35%)
TSLA   703.97 (-2.01%)
AMZN   3,139.33 (-0.22%)
NVDA   545.72 (-1.44%)
BABA   238.35 (-1.38%)
CGC   35.52 (+2.27%)
GE   13.04 (-0.53%)
MU   92.15 (-2.75%)
NIO   44.39 (-10.79%)
AMD   85.68 (-0.82%)
T   28.31 (+0.78%)
F   12.58 (+5.01%)
ACB   11.35 (+2.81%)
DIS   194.48 (-0.26%)
BA   224.02 (-0.16%)
NFLX   551.93 (+0.23%)
BAC   35.59 (-0.56%)
Log in
OTCMKTS:OCPNY

Olympus Stock Forecast, Price & News

$21.60
+0.32 (+1.50 %)
(As of 03/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$21.46
Now: $21.60▼
$21.76
50-Day Range
$18.17
MA: $20.08▼
$22.37
52-Week Range
$11.09
Now: $21.60▼
$22.99
Volume29,695 shs
Average Volume34,377 shs
Market Capitalization$29.61 billion
P/E Ratio77.14
Dividend Yield0.33%
Beta0.68
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through five segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, Imaging Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, video and other endoscopes system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Imaging Business segment provides digital cameras, IC and voice recorders, mirrorless interchangeable-lens cameras, and interchangeable lenses. The Others segment offers biomedical materials. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and GI- and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.
Olympus logo

Headlines

Nikkei Breaks Through 30,000 Level As Global Rally Continues
February 15, 2021 |  finance.yahoo.com
Olympus 9-month Profit From Cont. Ops. Declines; Revenue Down 8.5% - Quick Facts
February 12, 2021 |  nasdaq.com
Olympus Corp. ADR
January 29, 2021 |  wsj.com
Olympus Corporation 2021 Q2 - Results - Earnings Call Presentation
November 15, 2020 |  seekingalpha.com
Bariatric Surgery Devices Market – Global Industry Analysis, Size, Share, Trends and Forecast by 2025
November 7, 2020 |  marketwatch.com
Rigid Endoscopes Market Competitive Research And Precise Outlook 2020 To 2025
November 6, 2020 |  marketwatch.com
Olympus announces acquisition of FH ORTHO, an international orthopedics company in France
November 2, 2020 |  finance.yahoo.com
Olympus annonce l'acquisition de FH ORTHO, société internationale d'orthopédie en France
November 2, 2020 |  finance.yahoo.com
Olympus Corp. ADR (OCPNY)
October 28, 2020 |  nasdaq.com
Olympus edges Bonneville 1-0 for 5A girls' soccer state title
October 24, 2020 |  msn.com
Olympus Insurance Company Announces New Chief Financial Officer
October 15, 2020 |  prnewswire.com
Olympus Launches ENDO-AID, an AI-Powered Platform for Its Endoscopy System
October 9, 2020 |  au.finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Structural clay products
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:OCPNY
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.olympus-global.com
Phone813-3340-2111
Employees35,174
Year Founded1919

Debt

Debt-to-Equity Ratio1.02
Current Ratio1.88
Quick Ratio1.35

Price-To-Earnings

Trailing P/E Ratio77.14
Forward P/E Ratio135.00
P/E GrowthN/A

Sales & Book Value

Annual Sales$7.32 billion
Price / Sales4.04
Cash Flow$0.87 per share
Price / Cash Flow24.80
Book Value$2.51 per share
Price / Book8.61

Profitability

EPS (Most Recent Fiscal Year)$0.36
Net Income$475.36 million
Net Margins5.34%
Return on Equity10.82%
Return on Assets3.98%

Miscellaneous

Outstanding Shares1,370,915,000
Market Cap$29.61 billion
Next Earnings Date3/4/2021 (Estimated)
OptionableNot Optionable

MarketRank™

Overall MarketRank™

1.19 out of 5 stars

Medical Sector

847th out of 1,966 stocks

Structural Clay Products Industry

1st out of 3 stocks

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
$21.60
+0.32 (+1.50 %)
(As of 03/1/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OCPNY News and Ratings via Email

Sign-up to receive the latest news and ratings for OCPNY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Olympus (OTCMKTS:OCPNY) Frequently Asked Questions

Is Olympus a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Olympus in the last twelve months. There are currently 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "strong buy" Olympus stock.
View analyst ratings for Olympus or view top-rated stocks.

What stocks does MarketBeat like better than Olympus?

Wall Street analysts have given Olympus a "Strong Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Olympus wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Olympus?

Olympus saw a increase in short interest in the month of February. As of February 12th, there was short interest totaling 16,200 shares, an increase of 76.1% from the January 28th total of 9,200 shares. Based on an average daily volume of 102,000 shares, the short-interest ratio is currently 0.2 days.
View Olympus' Short Interest.

When is Olympus' next earnings date?

Olympus is scheduled to release its next quarterly earnings announcement on Thursday, March 4th 2021.
View our earnings forecast for Olympus.

How were Olympus' earnings last quarter?

Olympus Co. (OTCMKTS:OCPNY) released its quarterly earnings results on Wednesday, August, 5th. The company reported ($0.02) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.03) by $0.01. The firm had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.29 billion. Olympus had a trailing twelve-month return on equity of 10.82% and a net margin of 5.34%.
View Olympus' earnings history.

How has Olympus' stock been impacted by COVID-19?

Olympus' stock was trading at $17.6660 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, OCPNY shares have increased by 22.3% and is now trading at $21.60.
View which stocks have been most impacted by COVID-19.

Is Olympus a good dividend stock?

Olympus pays an annual dividend of $0.07 per share and currently has a dividend yield of 0.33%. The dividend payout ratio of Olympus is 19.44%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Olympus will have a dividend payout ratio of 11.48% next year. This indicates that Olympus will be able to sustain or increase its dividend.
View Olympus' dividend history.

Who are Olympus' key executives?

Olympus' management team includes the following people:
  • Hiroyuki Tsuji, Director
  • Mr. Yasuo Takeuchi, Pres, CEO, Representative Exec. Officer & Director (Age 64)
  • Mr. Chikashi Takeda, Exec. Officer & CFO (Age 59)
  • Mr. Nacho Abia, COO & Exec. Officer (Age 53)
  • Mr. Akihiro Taguchi, CTO & Exec. Officer (Age 63)
  • Mr. Stefan Kaufmann, Chief Admin. Officer, Exec. Officer & Director (Age 53) (LinkedIn Profile)
  • Ms. Donna Miller, Head of HQ Legal and Global Gen. Counsel
  • Ms. Caroline H. West, Chief Compliance Officer (Age 63)
  • Mr. Mark Miller, Global Chief Communications Officer
  • Shigeto Ohtsuki, Corp. Officer & HR Head

Who are some of Olympus' key competitors?

Some companies that are related to Olympus include Sanofi (SNY), CSL (CSLLY), Stryker (SYK), AstraZeneca (AZN), Intuitive Surgical (ISRG), GlaxoSmithKline (GSK), Gilead Sciences (GILD), Anthem (ANTM), Zoetis (ZTS), Becton, Dickinson and (BDX), Illumina (ILMN), Moderna (MRNA), GlaxoSmithKline (GSK), HCA Healthcare (HCA) and Bayer Aktiengesellschaft (BAYRY).
View all of OCPNY's competitors.

What is Olympus' stock symbol?

Olympus trades on the OTCMKTS under the ticker symbol "OCPNY."

How do I buy shares of Olympus?

Shares of OCPNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Olympus' stock price today?

One share of OCPNY stock can currently be purchased for approximately $21.60.

How much money does Olympus make?

Olympus has a market capitalization of $29.61 billion and generates $7.32 billion in revenue each year. The company earns $475.36 million in net income (profit) each year or $0.36 on an earnings per share basis.

How many employees does Olympus have?

Olympus employs 35,174 workers across the globe.

Does Olympus have any subsidiaries?

The following companies are subsidiares of Olympus: AVS Co Ltd, Aizu Olympus Co Ltd, Algram Group Ltd, Aomori Olympus Co Ltd, Arc Medical Design Limited, Image Stream Medical Inc, Nagano Olympus Co Ltd, Olympus (Beijing) Sales & Service Co Ltd, Olympus (China) Co Ltd, Olympus (GuangZhou) Industrial Co Ltd, Olympus (Malaysia) Sdn Bhd, Olympus (Thailand) Co Ltd, Olympus America Inc, Olympus America de Mexico SA de CV, Olympus Australia Pty Ltd, Olympus Austria Gesellschaft mbH, Olympus Belgium SA/NV, Olympus Canada Inc, Olympus Corporation of Asia Pacific Limited, Olympus Corporation of the Americas, Olympus Czech Group sro, Olympus Danmark A/S, Olympus Deutschland GmbH, Olympus Digital System Design Corp, Olympus Estonia Oü, Olympus Europa SE & Co KG, Olympus Finland OY, Olympus France SAS, Olympus Hong Kong and China Limited, Olympus Iberia SAU, Olympus Ireland, Olympus Italia SRL, Olympus Korea Co Ltd, Olympus Latin America Inc, Olympus Logitex Co Ltd, Olympus MEA FZ-LLC, Olympus Medical Science Sales Corp, Olympus Medical Systems Corp, Olympus Medical Systems India Private Limited, Olympus Medical Systems Vietnam Co Ltd, Olympus Memory Works Corp, Olympus Moscow Limited Liability Company, Olympus NDT Canada Inc, Olympus Nederland BV, Olympus New Zealand Limited, Olympus Norge A/S, Olympus Optical do Brasil Ltda, Olympus Polska sp zoo, Olympus Schweiz AG, Olympus Scientific Solutions Americas Corp, Olympus Scientific Solutions Technologies Inc, Olympus Singapore Pte Ltd, Olympus Soft Imaging Solutions GmbH, Olympus Surgical Technologies America Inc, Olympus Surgical Technologies Europe (Olympus Winter & Ibe GmbH), Olympus Sverige AB, Olympus Systems Corporation, Olympus Taiwan Co Ltd, Olympus Terumo Biomaterials Corp, Olympus Trading (Shanghai) Limited, Olympus UK & Ireland, Olympus Vietnam Co Ltd, Olympus doo Beograd, Olympus-RMS Corp, Olympus-Supportmate Corp, Shirakawa Olympus Co Ltd, Sony Olympus Medical Solutions Inc, Tecnologias Opticas e Digitais Lda, and TmediX Corporation.

When was Olympus founded?

Olympus was founded in 1919.

What is Olympus' official website?

The official website for Olympus is www.olympus-global.com.

Where are Olympus' headquarters?

Olympus is headquartered at SHINJUKU MONOLITH 3-1 NISHI-SHINJUKU 2-CHOME, TOKYO M0, 163-0914.

How can I contact Olympus?

Olympus' mailing address is SHINJUKU MONOLITH 3-1 NISHI-SHINJUKU 2-CHOME, TOKYO M0, 163-0914. The company can be reached via phone at 813-3340-2111 or via email at [email protected]


This page was last updated on 3/2/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.